Medizan Laboratories products and prices in Pakistan
Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.
Follow price changes 🔒 Company report (Pharma Pro)Private pharmaceutical manufacturer · Islamabad · Pakistan
Islamabad pharmaceutical manufacturer founded in 2005 with tablet, capsule and other branded-generic manufacturing operations.
Medizan Laboratories products in Pakistan
Medizan Laboratories (Pvt) Ltd has 12 medicine presentations registered in Pakistan under 9 brands, covering 5 generic medicines. Most of its products are in Anti-infectives, CNS & mental health and Gastrointestinal & hepatology. Its brands with the most registered strengths and packs are Synec (Ceftriaxone), Reflux (Omeprazole), Donresp-1 (Risperidone) and Donresp-2 (Risperidone). 12 products have an official DRAP price on MedInfoBase. See all 9 brands A to Z
What is sourced, and how recent is it?
Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.
Company profile
- Legal / official name
- Medizan Laboratories (Pvt.) Ltd.
- Company type
- Private pharmaceutical manufacturer
- Address
- Plot No. 313, Industrial Triangle, Kahuta Road, Islamabad, Pakistan
- Website
- medizanlabs.com ↗
- Phone
- +92 51 4490030
- Official contact
- Contact page ↗
- Corporate source details checked
- 16 Aug 2026
- Corporate profile completeness
- 88%
Company location
A sourced company location is recorded. Use the map link below for directions.
Portfolio at a glance
RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.
PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.
IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.
Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.
Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.
Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.
How complete is this profile?
Downloadable company intelligence charts
Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.
Therapeutic Portfolio Mix
Shows where the company portfolio is concentrated across broad therapeutic areas.
Portfolio distribution, not sales or market-share data.
Dosage Form Portfolio
Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.
Counts are product presentations, not production or sales volumes.
Equivalent Price Position
Shows whether safely comparable products are below, near or above the peer median unit price.
This is price-position intelligence, not sales, demand or market-share data.
Closest Portfolio Competitors
Highlights other manufacturers with the greatest generic overlap with this company portfolio.
Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.
Therapeutic areas
High-level clinical areas represented by this company’s current MedInfoBase portfolio.
Drug classes
More specific classes derived from the canonical generic and preserved curated classifications.
Dosage forms
How MedInfoBase classifies the portfolio
MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.
Deepest brand families
Unit-price positioning vs equivalent products
See where Medizan Laboratories (Pvt) Ltd is priced against the market
12 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.
How MedInfoBase calculates price position
Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.
Portfolio overlap
Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.
🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock
Observed database signals
These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.
Medicine portfolio
This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.
| Brand | Generic | Strength | Form | Pack | Registration | Source-listed price | Unit price | Price position |
|---|---|---|---|---|---|---|---|---|
| Abro 10mg TabletRegistry verified | Ebastine | — | — | — | 038806Official source ↗ | No indexed price | — | — |
| Acotay 100mg TabletRegistry verified | Acotiamide HCl Hydrate | — | — | — | 135558Official source ↗ | No indexed price | — | — |
| Admont 4mg SachetRegistry verified | Montelukast as sodium | — | — | — | 138535Official source ↗ | No indexed price | — | — |
| Apropil 12.5mg TabletsRegistry verified | Aprocitentan | — | — | — | 133905Official source ↗ | No indexed price | — | — |
| AS R 100 CapsuleRegistry verified | Diclofenac | — | — | — | 002664-EXOfficial source ↗ | No indexed price | — | — |
| Cabrova 0.5 mg TabletsRegistry verified | Cabergoline | — | — | — | 135640Official source ↗ | No indexed price | — | — |
| Caripil 1.5mg CapsuleRegistry verified | Cariprazine(as cariprazine hydrochloride) | — | — | — | 135391Official source ↗ | No indexed price | — | — |
| Caripil 3mg CapsuleRegistry verified | Cariprazine Hydrochloride equivalent to Cariprazine | — | — | — | 135392Official source ↗ | No indexed price | — | — |
| Caripil 4.5mg CapsuleRegistry verified | Cariprazine(as cariprazine hydrochloride) | — | — | — | 135389Official source ↗ | No indexed price | — | — |
| Caripil 6mg CapsuleRegistry verified | Cariprazine(as cariprazine hydrochloride) | — | — | — | 135390Official source ↗ | No indexed price | — | — |
| Dapopil 1mg TabletRegistry verified | Daprodustat | — | — | — | 135393Official source ↗ | No indexed price | — | — |
| Dapopil 2mg TabletRegistry verified | Daprodustat | — | — | — | 135394Official source ↗ | No indexed price | — | — |
| Dapopil 6mg TabletRegistry verified | Daprodustat | — | — | — | 135395Official source ↗ | No indexed price | — | — |
| Darixo 25mg TabletsRegistry verified | Daridorexant as HCl | — | — | — | 135681Official source ↗ | No indexed price | — | — |
| Darixo 50mg TabletsRegistry verified | Daridorexant as HCl | — | — | — | 135682Official source ↗ | No indexed price | — | — |
| Dexjet 30mg CapsuleRegistry verified | Each Capsule Dexlansoprazole as dual Delayed Release Pellets | — | — | — | 129494Official source ↗ | No indexed price | — | — |
| Dexjet 60mg CapsuleRegistry verified | Dexlansoprazole as Dual Delayed Release Pellets | — | — | — | 129495Official source ↗ | No indexed price | — | — |
| Donresp-1 | Risperidone | 1 mg | Tablet | 10`s | 060160 | PKR 224.00 | PKR 22.40/tablet | 🔒 Pharma Pro |
| Donresp-2 | Risperidone | 2 mg | Tablet | 10`s | 060166 | PKR 367.07 | PKR 36.71/tablet | 🔒 Pharma Pro |
| Donresp-3 | Risperidone | 3 mg | Tablet | 10`s | 060165 | PKR 564.72 | PKR 56.47/tablet | 🔒 Pharma Pro |
| Dunib 6mg TabletsRegistry verified | Deucravacitinib | — | — | — | 133991Official source ↗ | No indexed price | — | — |
| Dydropil 10mg TabletsRegistry verified | DYDROGESTERONE | — | — | — | 133914Official source ↗ | No indexed price | — | — |
| Elagix 150mg TabletRegistry verified | Elagolix sodium Equivalent to Elagolix | — | — | — | 134199Official source ↗ | No indexed price | — | — |
| Elagix 200mg TabletRegistry verified | Elagolix sodium Equivalent to Elagolix | — | — | — | 134200Official source ↗ | No indexed price | — | — |
| Eligest 2mg/0.5mg TabletsRegistry verified | Estradiol Valerate, Norgestrel | — | — | — | 133996Official source ↗ | No indexed price | — | — |
| Etrasa 2mg TabletsRegistry verified | Etrasimod as Arginine | — | — | — | 136778Official source ↗ | No indexed price | — | — |
| Fenac-EC 540 CapsuleRegistry verified | Diclofenac | — | — | — | 002662-EXOfficial source ↗ | No indexed price | — | — |
| Hysone 100 mg InjectionRegistry verified | Hydrocortisone | — | — | — | 127501Official source ↗ | No indexed price | — | — |
| Hysone 250mg InjectionRegistry verified | Hydrocortisone | — | — | — | 127502Official source ↗ | No indexed price | — | — |
| Hysone 500 mg InjectionRegistry verified | Hydrocortisone | — | — | — | 127503Official source ↗ | No indexed price | — | — |
| Laslid 100mg TabletRegistry verified | Lasmiditan hemisuccinate equivalent to Lasmiditan | — | — | — | 135304Official source ↗ | No indexed price | — | — |
| Laslid 50mg TabletRegistry verified | Lasmiditan hemisuccinate equivalent to Lasmiditan | — | — | — | 135303Official source ↗ | No indexed price | — | — |
| Leeght 500mg TabletRegistry verified | Paracetamol | — | — | — | 038801Official source ↗ | No indexed price | — | — |
| Macitil 10mg TabletsRegistry verified | Macitentan | — | — | — | 138534Official source ↗ | No indexed price | — | — |
| Macrozan 500mg TabletsRegistry verified | Azithromycin(as Dihydrate) | — | — | — | 003063-EXOfficial source ↗ | No indexed price | — | — |
| Medidsic TabletsRegistry verified | Orphenadrine Citrate, Paracetamol | — | — | — | 003061-EXOfficial source ↗ | No indexed price | — | — |
| Medinib 10mg TabletsRegistry verified | Tofacitinib Citrate Eq. to Tofacitinib | — | — | — | 134175Official source ↗ | No indexed price | — | — |
| Medipenem 1gm Injection IVRegistry verified | Meropenem as trihydrate blended with sodium bicarbonate | — | — | — | 119435Official source ↗ | No indexed price | — | — |
| Medipenem 1gm Injection IVRegistry verified | Meropenem as trihydrate | — | — | — | 1194535Official source ↗ | No indexed price | — | — |
| Medipenem 500mg Injection IVRegistry verified | Meropenem as trihydrate | — | — | — | 119434Official source ↗ | No indexed price | — | — |
| Norepil 5mg TabletsRegistry verified | Norethisterone | — | — | — | 133915Official source ↗ | No indexed price | — | — |
| Nosocom 1gm InjectionRegistry verified | Cefepime hydrochloride eq to Cefepime | — | — | — | 132277Official source ↗ | No indexed price | — | — |
| Nosocom 500mg InjectionRegistry verified | Cefepime hydrochloride eq to Cefepime | — | — | — | 132278Official source ↗ | No indexed price | — | — |
| Nuloc 20 CapsuleRegistry verified | Esomeprazole Magnesium (as Enteric Coated Microgranules) | — | — | — | 038815Official source ↗ | No indexed price | — | — |
| Nuloc 40 CapsuleRegistry verified | Esomeprazole Magnesium (as Enteric Coated Microgranules) | — | — | — | 038816Official source ↗ | No indexed price | — | — |
| Olan-5 | Olanzapine | 5 mg | Tablet | 10’s | 048912 | PKR 186.29 | PKR 18.63/tablet | 🔒 Pharma Pro |
| Oronight 500/25mg TabletRegistry verified | Diphenhydramine Hydrochloride, Paracetamol | — | — | — | 135397Official source ↗ | No indexed price | — | — |
| Orozan TabletsRegistry verified | Orphenadrine citrate, Paracetamol | — | — | — | 038797Official source ↗ | No indexed price | — | — |
| Pimalt 100mg TabletRegistry verified | Iron III hydroxide polymaltose complex eq. to elemental iron | — | — | — | 038819Official source ↗ | No indexed price | — | — |
| Pypex 20mg CapsuleRegistry verified | Piroxicam | — | — | — | 038817Official source ↗ | No indexed price | — | — |
All 9 Medizan Laboratories brands in Pakistan
- Donresp-1 Risperidone · 1 mg tablet
- Donresp-2 Risperidone · 2 mg tablet
- Donresp-3 Risperidone · 3 mg tablet
- Olan-5 Olanzapine · 5 mg tablet
- Reflux Omeprazole · 20 mg capsule, 40 mg injection
- Synec Ceftriaxone · 1 g injection, 250 mg injection, 500 mg injection
- Zanxim Cefixime · 400 mg capsule
- Zanxim-100mg DS Cefixime · 100 mg/5 mL suspension
- Zanxim-200mg DS Cefixime · 200 mg/5 mL suspension
Medizan Laboratories: common questions
How many products does Medizan Laboratories have in Pakistan?
Medizan Laboratories (Pvt) Ltd has 12 registered medicine presentations in Pakistan, sold under 9 brands and covering 5 generic medicines.
What are the main brands of Medizan Laboratories?
By number of registered strengths and packs, its largest brands are Synec (Ceftriaxone), Reflux (Omeprazole), Donresp-1 (Risperidone), Donresp-2 (Risperidone) and Donresp-3 (Risperidone). This is not a sales ranking.
Which therapy areas does Medizan Laboratories cover?
The most products are in Anti-infectives (6), CNS & mental health (4) and Gastrointestinal & hepatology (2).
Where can I see Medizan Laboratories medicine prices?
Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.
MedInfoBase company-intelligence methodology
This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.
Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.
Cite this record
Manufacturer recordRecords change over time. Please cite the access date so readers can locate the version you used.